Loading...
Improving access to effective antiretroviral therapy in resource-poor areas could dramatically improve the health of HIV-infected patients and reduce the damaging stigma associated with HIV/AIDS. Concerns persist, however, about whether generic antiretrovirals can achieve acceptable outcomes in these regions. New study results from Haiti are encouraging in this regard: They describe the first 1004 HIV-infected, treatment-naive patients to have received antiretroviral therapy in Port-au-Prince since March 2003 (94 children and 910 adults, including adolescents).
At baseline, adults had a median CD4 count of 131 cells/mm3, and children had a median CD4 percentage of 13%. Most patients (47% of adults and 62% of children) received AZT + 3TC + ef…